Contact Molecules for Homologous Proteins | ||||
![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [SupCon3D] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
2918724 | 365 | 500 | P04439(HLAA_HUMAN) | RecName: Full=HLA class I histocompatibility antigen, A alpha chain;AltName: Full=Human leukocyte antigen A; Short=HLA-A;Flags: Precursor; |
QUERYSEQ |
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYRQDAYDGKDYIAL NEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEL SSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV |
365 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() ![]() |
1-24 | SIGNAL | |
![]() ![]() |
25-365 | CHAIN | /note="HLA class I histocompatibility antigen, A alpha chain" /id="PRO_0000018815" |
![]() ![]() ![]() |
25-308 | TOPO_DOM | /note="Extracellular" |
![]() ![]() ![]() |
309-332 | TRANSMEM | /note="Helical" |
![]() ![]() |
333-365 | TOPO_DOM | /note="Cytoplasmic" |
![]() ![]() ![]() |
209-295 | DOMAIN | /note="Ig-like C1-type" |
![]() ![]() ![]() |
3-11 | REGION | /note="VL9 epitope" |
![]() ![]() ![]() |
25-114 | REGION | /note="Alpha-1" |
![]() ![]() ![]() |
115-206 | REGION | /note="Alpha-2" |
![]() ![]() ![]() |
207-298 | REGION | /note="Alpha-3" |
![]() ![]() ![]() |
299-308 | REGION | /note="Connecting peptide" |
![]() ![]() |
339-365 | REGION | /note="Disordered" |
![]() ![]() ![]() |
31-31 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
97-97 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
108-108 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
140-140 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" |
![]() ![]() ![]() |
167-167 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
170-170 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" |
![]() ![]() ![]() |
195-195 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-365 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
365 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 99.6 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NEF_HV1Z6 Negative factor[10 aa] | A | 89.3 /97.5 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MYPR_HUMAN MYELIN PROTEOLIPID PROTEIN[9 aa] | A | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | D30 TCR beta chain[244 aa] | A | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[364 aa] | D | 100.0 /100.0 |
11 /11 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[365 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[364 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN wild-type PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
24 /24 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
28 /28 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor, alpha chain[187 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T cell receptor, beta chain[247 aa] | A | 100.0 /100.0 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBAC Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | A | 87.0 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa] | A | 100.0 /100.0 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[348 aa] | D | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | PDIA3_HUMAN Protein disulfide-isomerase A3[459 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell receptor beta chain[238 aa] | A | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[238 aa] | A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T cell receptor, alpha chain[185 aa] | A | 100.0 /100.0 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IgG, Fab Heavy Chain V2[216 aa] | D | 100.0 /100.0 |
16 /16 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | KRAS G12V (7-16)[10 aa] | D | 100.0 /100.0 |
19 /19 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN KRAS G12V peptide (VVVGAVGVGK)[10 aa] | A | 81.8 /97.5 |
22 /22 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IgG, Fab Light Chain V2[214 aa] | D | 100.0 /100.0 |
8 /8 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_I46A1 Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
30 /30 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | G12V-TCR beta chain[240 aa] | BA | 100.0 /100.0 |
11 /11 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | G12V-TCR alpha chain[201 aa] | BA | 100.0 /100.0 |
7 /7 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[178 aa] | A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | P1B7 Heavy Chain[217 aa] | A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | P1B7 Light Chain[213 aa] | A | 100.0 /100.0 |
9 /9 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN GTPase KRas, N-terminally processed[9 aa] | A | 100.0 /100.0 |
22 /22 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN Phosphatidylinositol 4,5-bisphosphate 3-kinase cat.. | A | 100.0 /100.0 |
24 /24 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN Phosphatidylinositol 4,5-bisphosphate 3-kinase cat.. | A | 100.0 /100.0 |
27 /27 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
22 /22 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 88.0 /97.5 |
25 /25 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | AZOBENZENE-CONTAINING PEPTIDE[7 aa] | A | 76.9 /97.5 |
13 /13 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Heavy chain[216 aa] | A | 100.0 /97.4 |
10 /10 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Light chain[216 aa] | A | 75.0 /97.4 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | A | 90.9 /97.5 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RASK_HUMAN KRAS G12R peptide (VVVGARGVGK)[8 aa] | D | 85.7 /97.5 |
21 /21 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[181 aa] | A | 91.7 /97.5 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M1_INBAC Matrix protein 1 peptide SALEWIKNK[9 aa] | A | 84.6 /97.5 |
26 /26 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN KRAS G12R peptide (VVVGARGVGK)[10 aa] | A | 80.0 /97.5 |
20 /20 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.5 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 86.7 /97.5 |
30 /30 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ELFSYLIEK peptide[9 aa] | A | 100.0 /100.0 |
31 /31 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[190 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[237 aa] | A | 100.0 /100.0 |
7 /7 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_CVHSA SARS NUCLEOCAPSID PEPTIDE[9 aa] | A | 89.7 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA polymerase PEPTIDE HOMOLOGUE[10 aa] | A | 88.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4P6M5_9INFA Nucleocapsid protein[11 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4X2K3_9INFA Nucleoprotein[11 aa] | A | 84.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2[190 .. | C | 100.0 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A14_VACCW peptide from Virion membrane protein A14[9 aa] | C | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein 2 epit.. | A | 84.6 /97.4 |
26 /26 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 81.8 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein-2 epit.. | A | 88.9 /97.4 |
18 /18 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS1 peptide[10 aa] | A | 92.6 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS3 peptide[10 aa] | A | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | A | 75.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR[5 aa] | A | 76.9 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ALA-MET-TYR-LYS[4 aa] | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[7 aa] | D | 91.3 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[6 aa] | G | 90.9 /97.4 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[191 aa] | A | 91.7 /97.4 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[246 aa] | A | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | A | 88.5 /97.5 |
26 /26 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[163 aa] | A | 90.0 /97.4 |
10 /10 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBSI Nucleoprotein peptide KTNGNAFIGK[10 aa] | A | 85.7 /97.5 |
28 /28 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NS1_INBSJ Non-structural protein 1 peptide RVLVNGTFLK[10 aa].. | A | 87.1 /97.4 |
31 /31 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide KRAS-G12V-9[9 aa] | A | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN KRAS G12C peptide (VVVGACGVGK)[10 aa] | A | 84.0 /97.5 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN GTPase KRas, N-terminally processed[10 aa] | A | 100.0 /100.0 |
19 /19 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | R023 Fab light chain[107 aa] | A | 100.0 /100.0 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | R023 Fab heavy chain[117 aa] | A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T-cell receptor alpha chain[183 aa] | C | 90.9 /97.4 |
11 /11 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain[236 aa] | C | 100.0 /97.4 |
9 /9 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.1 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha chain[198 aa] | A | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta chain[240 aa] | A | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TCR alpha chain[194 aa] | C | 84.6 /96.7 |
13 /13 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TCR beta chain[242 aa] | C | 100.0 /96.7 |
7 /7 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN KRAS-G12wt-9[9 aa] | A | 88.0 /96.7 |
25 /25 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1Z2 nonamer reverse transcriptase (AIFQSSMTK)[9 aa] | A | 86.2 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | peptide[9 aa] | A | 85.2 /97.4 |
27 /27 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | Nucleoprotein[9 aa] | A | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | MTB[9 aa] | A | 79.3 /96.0 |
29 /29 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | A | 75.0 /94.5 |
28 /28 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR F50 beta chain[240 aa] | B | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[247 aa] | A | 100.0 /94.5 |
7 /7 |
F6IQR9_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | NRAS Q61K peptide[10 aa] | A | 76.0 /94.5 |
25 /25 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | ILE-LEU-ASP-THR-ALA-GLY-LYS-GLU-GLU-TYR[10 aa] | A | 77.4 /94.5 |
31 /31 |
F6IQR9_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR ALPHA[202 aa] | A | 75.0 /94.5 |
12 /12 |
F6IQR9_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-LEU-ASP-THR-ALA-GLY-ARG-GLU-GLU-TYR[10 aa] | A | 76.7 /94.5 |
30 /30 |
F6IQR9_HUMAN human leukocyte antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAG1_HUMAN MELANOMA-ASSOCIATED ANTIGEN 1[9 aa] | A | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | HYB3 HEAVY CHAIN[223 aa] | A | 88.9 /94.5 |
9 /9 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | HYB3 LIGHT CHAIN[210 aa] | A | 100.0 /94.5 |
6 /6 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | Light chain from antibody JTK191b E07[205 aa] | BA | 66.7 /94.5 |
6 /6 |
F6IQR9_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | Light chain from antibody JTK191b E07[205 aa] | H | 100.0 /94.5 |
4 /4 |
F6IQR9_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa] | A | 80.0 /94.5 |
25 /25 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A0B4J279_HUMAN TCA_HUMAN Protein TRAV21,T-cell receptor alpha chain C regio.. | A | 66.7 /94.5 |
9 /9 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A0A578_HUMAN K7N5M4_HUMAN Protein TRBV5-1,Human nkt tcr beta chain[241 aa] | A | 80.0 /94.5 |
5 /5 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TITIN_HUMAN Titin[9 aa] | A | 78.3 /94.5 |
23 /23 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALK[10 aa] | A | 74.1 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | Fab heavy chain from antibody JTK191b E07[220 aa] | BA | 70.0 /94.5 |
10 /10 |
F6IQR9_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | Fab heavy chain from antibody JTK191b E07[220 aa] | H | 100.0 /94.5 |
2 /2 |
F6IQR9_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | peptide[9 aa] | BA | 73.1 /94.5 |
26 /26 |
F6IQR9_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLU-VAL-ASP-ASN-ALA-THR-ARG-PHE-ALA-SER-VAL-TYR[12.. | A | 75.0 /94.5 |
28 /28 |
HLA class I heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CCND2_HUMAN G1/S-specific cyclin-D2[10 aa] | A | 83.9 /94.2 |
31 /31 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 81.5 /94.2 |
27 /27 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | influenza A NP145-156 peptide[7 aa] | A | 79.2 /94.2 |
24 /24 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | BOUND PEPTIDE FRAGMENT[3 aa] | A | 75.0 /94.1 |
12 /12 |
A6YT91_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SARS-CoV-2 Spike-derived peptide S976-984 S982A mu.. | A | 82.1 /93.1 |
28 /28 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[98 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[99 aa] | F | 93.9 /93.1 |
33 /33 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.9 /94.2 |
33 /33 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CD8A_HUMAN T-CELL CORECEPTOR CD8[114 aa] | A | 100.0 /93.1 |
13 /13 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CD8A_HUMAN T-CELL CORECEPTOR CD8[114 aa] | A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PEPTIDE P1049 (ALWGFFPVL)[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TAX PEPTIDE[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA-A 0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T CELL RECEPTOR ALPHA[190 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA-A 0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T CELL RECEPTOR BETA[242 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA-A 0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell receptor, beta chain[243 aa] | A | 75.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T Cell Receptor Mel8, Beta Chain[245 aa] | F | 93.8 /93.1 |
16 /16 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa] | A | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA-A2*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GP2 PEPTIDE[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GP2 PEPTIDE[9 aa] | A | 88.5 /93.1 |
26 /26 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ENV_HV1B8 HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 .. | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CORA_HBVIL HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[.. | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M1_IAPUE INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a.. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | M1_I34A1 Matrix protein 1[9 aa] | C | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9.. | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAGA4_HUMAN MELANOMA-ASSOCIATED ANTIGEN 4[10 aa] | A | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | MAGA4_HUMAN Melanoma-associated antigen 4[10 aa] | I | 78.3 /93.1 |
23 /23 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 9 RESIDUE PEPTIDE[9 aa] | A | 86.4 /93.1 |
22 /22 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 9 RESIDUE PEPTIDE[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 9 RESIDUE PEPTIDE[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | US02_HCMVA cytomegalovirus protein US2[95 aa] | A | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-cell Receptor alpha chain[194 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell Receptor beta chain[237 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | LIRB1_HUMAN leukocyte immunoglobulin-like receptor 1[183 aa] | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAGA3_HUMAN PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN PROTEIN (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ERBB2_HUMAN GP2 PEPTIDE[9 aa] | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA-A2.1 HEAVY CHAIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | gag peptide[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CRTC_HUMAN DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1B[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Q6PIZ8_HUMAN T-cell Receptor, alpha chain[193 aa] | A | 75.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Transcriptional activator TAX[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6-Tcr[200 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melan-A/MART-1(26-35) peptide[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Peptide[9 aa] | A | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[9 aa] | A | 75.0 /93.1 |
20 /20 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a.. | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ENV_HV1MA ENVELOPE GLYCOPROTEIN GP160[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POF1B_HUMAN decameric peptide from Protein POF1B[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G.. | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide 38-46 from cell division cycle 25b (CDC25b.. | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | phospho-peptide 38-46 from cell division cycle 25b.. | A | 86.4 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide 1097-1105 from insulin receptor substrate .. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | phospho-peptide 1097-1105 from insulin receptor s.. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YYH6_9HIV1 HIV-1 peptide[10 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NYESO-1 peptide[9 aa] | D | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Antibody light chain[212 aa] | D | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | Antibody heavy chain[220 aa] | D | 80.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | Heavy chain[214 aa] | A | 100.0 /93.1 |
1 /1 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Tel1p peptide[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | WT1_HUMAN WT126 peptide[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VME1_CVHSA Membrane protein[9 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN NYESO-1 peptide analogue[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 10-meric peptide from Hemagglutinin[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q1WDM0_9INFA 10-meric peptide from Hemagglutinin[10 aa] | A | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | WT1_HUMAN Wilms tumor protein[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptidomimetic ELA-1[8 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptidomimetic ELA-1.1[8 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | A7UMS0_EBVG BSLF2/BMLF1 protein[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-CELL RECEPTOR, ALPHA CHAIN[195 aa] | A | 81.8 /93.1 |
11 /11 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-CELL RECEPTOR, BETA CHAIN[245 aa] | A | 85.7 /93.1 |
7 /7 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PN45428 TCR beta chain[287 aa] | I | 66.7 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HuD (G2L,I9V) peptide[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HuD peptide[9 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HuD (G2L) peptide[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Mart-1 (26-35) peptide[10 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF5 alpha chain[199 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human T Cell Receptor Mel8, Alpha Chain[193 aa] | F | 75.0 /93.1 |
4 /4 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF5 beta chain[242 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF4 alpha chain[195 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF4 beta chain[242 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TAX(Y5F) peptide[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q692E0_CVHSA Md3-C9 peptide derived from Membrane glycoprotein[.. | A | 82.6 /93.1 |
23 /23 |
Q53Z42_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | INS_HUMAN Insulin[10 aa] | A | 85.7 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[200 aa] | A | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[199 aa] | A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[246 aa] | A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV peptide KVAELVHFL[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-based altered-peptide ligand KVAEIVHFL[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-based altered-peptide ligand KVAELVWFL[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | E3GL_ADE06 Early E3 18.5 kDa glycoprotein[99 aa] | A | 93.3 /93.1 |
15 /15 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | FLT Cognate peptide[10 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Immunogenic peptide[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | E1A heteroclitic Melanoma peptide[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | G4A heteroclitic Melanoma peptide[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | L8A heteroclitic Melanoma peptide[10 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Q9QAC5_HBV Core protein[9 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LSP1_HUMAN Lymphocyte-specific protein 1[12 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | AMPD2_HUMAN AMP deaminase 2[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | AZOBENZENE-CONTAINING PEPTIDE[6 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ESK1[212 aa] | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | IMMUNOGLOBULIN HEAVY CHAIN[223 aa] | A | 77.8 /93.1 |
18 /18 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 77.3 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MVWGPDPLYV[10 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 80.0 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Marker peptide[10 aa] | F | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa] | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GP100 peptide YLEPGPVTA[9 aa] | A | 87.0 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | PMEL_HUMAN Tumor-associated antigentic peptide gp100[9 aa] | F | 82.8 /93.1 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human TCR Light Chain[204 aa] | A | 71.4 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human TCR Heavy Chain[244 aa] | A | 90.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | PF6 TCR alpha chain[191 aa] | C | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | PF6 TCR beta chain[237 aa] | C | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain[285 aa] | F | 90.0 /93.1 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCRalpha chain[200 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCRalpha chain[201 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-LEU-GLY-LYS-PHE-LEU-HIS-TRP-LEU[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-cell receptor Alpha chain[201 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T-cell receptor beta chain[242 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR F50 alpha chain[202 aa] | B | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T cell receptor alpha chain[192 aa] | C | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T cell receptor beta chain[241 aa] | C | 100.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | NS3 peptide[10 aa] | C | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | K7N5M3_HUMAN DMF5 alpha chain,DMF5 alpha chain[185 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Q6PJ56_HUMAN Q6PJ56_HUMAN TRA@ protein[198 aa] | A | 87.5 /93.1 |
8 /12 |
B2MG_HUMAN 1A02_HUMAN MART1 PEPTIDE-BETA-2-MICROGLOBULIN-HLA-A*02 CHIMER.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G.. | A | 87.5 /93.1 |
8 /9 |
B2MG_HUMAN 1A02_HUMAN MART1 PEPTIDE-BETA-2-MICROGLOBULIN-HLA-A*02 CHIMER.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Mel5 TCR, beta chain[244 aa] | A | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RETR2_HUMAN Reticulophagy regulator 2[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa] | A | 80.0 /93.1 |
20 /20 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | RTA_EBVG Replication and transcription activator[9 aa] | AB | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Melanoma antigen variant[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TVA22_HUMAN K7N5M3_HUMAN T cell receptor alpha variable 22,Human nkt tcr al.. | A | 80.0 /93.1 |
15 /15 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TVBK2_HUMAN K7N5M4_HUMAN T cell receptor beta variable 11-2,Human nkt tcr b.. | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-cell receptor alpha chain[197 aa] | A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T4H2 T cell receptor alpha chain[201 aa] | A | 81.8 /93.1 |
11 /11 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell receptor beta chain[244 aa] | A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | a7b2 ALPHA CHAIN[192 aa] | A | 80.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF4 Beta CHAIN[242 aa] | A | 100.0 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Alpha chain of engineered high affinity T-cell rec.. | A | 83.3 /93.1 |
12 /12 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | T cell receptor, alpha chain[108 aa] | A | 100.0 /93.1 |
9 /9 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | T cell receptor, beta chain[112 aa] | A | 83.3 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SILv44 T cell receptor alpha chain[197 aa] | C | 71.4 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PMEL_HUMAN Melanocyte protein PMEL[9 aa] | C | 82.8 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | C | 88.9 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | A | 88.0 /93.1 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | Immunoglobulin heavy chain H2[222 aa] | J | 83.3 /93.1 |
6 /6 |
U5YKE0_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa] | A | 76.9 /93.1 |
26 /26 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa] | A | 87.5 /93.1 |
24 /24 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa] | A | 78.3 /93.1 |
23 /23 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SARS-CoV-2 T-cell Epitope S1[9 aa] | A | 84.0 /93.1 |
25 /25 |
A0A5H2UU57_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 76.0 /93.1 |
25 /25 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 80.8 /93.1 |
26 /26 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 87.0 /93.1 |
23 /23 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 77.8 /93.1 |
27 /27 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 79.3 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain (TRBV/TRBC)[238 aa] | I | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | MAGAA_HUMAN Melanoma-associated antigen 10[9 aa] | I | 80.8 /93.1 |
26 /26 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T-cell receptor alpha chain[243 aa] | F | 83.3 /93.1 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Fab heavy chain[212 aa] | E | 80.0 /93.1 |
10 /10 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Fab light chain[211 aa] | E | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa] | E | 82.8 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa] | A | 82.8 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 6-11 T cell receptor alpha chain[200 aa] | A | 100.0 /93.1 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | I27RA_HUMAN Interleukin-27 receptor subunit alpha[17 aa] | A | 80.6 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | I27RA_HUMAN Interleukin-27 receptor subunit alpha[16 aa] | C | 77.8 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Light chain[211 aa] | A | 90.0 /93.1 |
10 /10 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' peptide [9 aa] | A | 86.2 /93.1 |
29 /29 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PGM5 peptide (465-473) (H5Y)[9 aa] | A | 78.9 /93.1 |
19 /19 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG.. | A | 81.8 /93.1 |
22 /22 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain[242 aa] | D | 100.0 /93.1 |
5 /5 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | D | 82.8 /93.1 |
29 /29 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | PA2.1 Fab Heavy Chain[215 aa] | A | 83.3 /93.1 |
12 /12 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | PA2.1 Fab Light Chain[217 aa] | A | 66.7 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | PN45545 TCR alpha chain[257 aa] | I | 81.8 /93.1 |
11 /11 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | PN45545 TCR beta chain[287 aa] | I | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | PN45428 TCR alpha chain[251 aa] | I | 100.0 /93.1 |
7 /7 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TLF: TLFDEPPPL[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2[9 aa] | A | 85.2 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa].. | A | 80.0 /93.1 |
10 /10 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SARS-CoV-2 specific private TCR RLQ7 beta[244 aa] | A | 100.0 /93.1 |
11 /11 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Sorting nexin 24 (127-135)(P132L) peptide[9 aa] | A | 80.8 /93.1 |
26 /26 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Sorting nexin 24 (127-135) peptide[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TRACeR-I[118 aa] | B | 87.5 /93.1 |
24 /24 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TRACeR-I[118 aa] | F | 100.0 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TRACeR-I[124 aa] | B | 100.0 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' peptide VVFLHVTYV [9 aa] | A | 80.8 /92.8 |
26 /26 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' peptide VLNDILSRL [9 aa] | A | 85.2 /92.8 |
27 /27 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 80.0 /92.4 |
25 /25 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 77.8 /92.4 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[3 aa] | A | 86.7 /92.4 |
15 /15 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | A0A1U9YFU1_9PAPI Major capsid protein L1[9 aa] | A | 70.4 /92.3 |
27 /27 |
Q5SPM2_HUMAN HLA class I heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | A0A1U9YFU1_9PAPI Major capsid protein L1[9 aa] | A | 76.7 /92.3 |
30 /30 |
Q5SPM2_HUMAN HLA class I heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[12 aa] | A | 75.0 /92.3 |
28 /28 |
Q5SPM2_HUMAN HLA class I heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 66.7 /92.3 |
24 /24 |
Q5SPM2_HUMAN HLA class I heavy chain |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MOV
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MOV
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MOV
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ARG
|
A | 100.0 /94.1 |
11 /11 |
A6YT91_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
S |
3IB
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
TAM
|
A | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
TAM
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
PE8
|
D | 70.0 /93.1 |
10 /10 |
A0A5B8RNS7_HUMAN MHC class I antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
NA
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
NA
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NA
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NA
|
A | 66.7 /92.4 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NA
|
A | 100.0 /92.4 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
NA
|
A | 100.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /97.5 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
NA
|
A | 100.0 /94.2 |
3 /3 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
NA
|
C | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
NA
|
A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
QA |
CL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
FB |
CL
|
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
GB |
CL
|
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA |
CL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
MC |
CL
|
HA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
CL
|
A | 50.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CL
|
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /97.5 |
3 /3 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CL
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
CL
|
C | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
CL
|
E | 83.3 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /94.2 |
1 /1 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MG
|
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 33.3 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
C | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
A | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
MG
|
A | 50.0 /94.2 |
2 /2 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NI
|
A | 0.0 /94.2 |
1 /1 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
NI
|
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
IOD
|
A | 100.0 /94.2 |
3 /3 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 0.0 /93.1 |
1 /1 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
BR
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
3NI
|
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
3NI
|
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ZN
|
A | 100.0 /92.8 |
2 /2 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-.. | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | A | 90.9 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | F6IQR9_HUMAN MHC class I antigen (Fragment)[274 aa] | BA | 91.7 /94.5 |
12 /12 |
F6IQR9_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | F6IQR9_HUMAN MHC class I antigen (Fragment)[274 aa] | BA | 100.0 /94.5 |
13 /13 |
F6IQR9_HUMAN MHC class I antigen (Fragment) |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
D | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
GOL
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
2 /2 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
GOL
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
FMT
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
FMT
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
FMT
|
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
FMT
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
FMT
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
FMT
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
FMT
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
FMT
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
FMT
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
FMT
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
FMT
|
G | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
FMT
|
A | 100.0 /100.0 |
2 /2 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
FMT
|
A | 100.0 /100.0 |
2 /2 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
TOE
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
IMD
|
C | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
IMD
|
A | 100.0 /99.6 |
7 /7 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
IMD
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 25.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
JB |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
SB |
EDO
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
EDO
|
F | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
E | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
C | 87.5 /97.4 |
8 /8 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
EDO
|
C | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ALA
|
A | 100.0 /94.1 |
2 /2 |
A6YT91_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ACT
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ACT
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ACT
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ACT
|
A | 66.7 /92.4 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ACT
|
A | 50.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ACT
|
A | 100.0 /92.4 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ACT
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ACT
|
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ACT
|
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
1PG
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
1PG
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /97.5 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 66.7 /97.5 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /97.5 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
2 /2 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 71.4 /94.5 |
7 /7 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /94.5 |
1 /1 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /94.5 |
3 /3 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /94.5 |
2 /2 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
UA |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /94.2 |
4 /4 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
D | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
G | 100.0 /97.4 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
B | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
IPA
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
IPA
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
IPA
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
IPA
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
IPA
|
C | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
IPA
|
C | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MES
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MES
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MES
|
A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MES
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
PG4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
PG4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
PG4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
PG4
|
A | 100.0 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
PG4
|
A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PG4
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PG4
|
E | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
PG4
|
E | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
PG4
|
G | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
ACY
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
S |
ACY
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
PEG
|
A | 100.0 /97.4 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
E | 83.3 /97.5 |
6 /6 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
PEG
|
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
PEG
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
PEG
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
PEG
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
PEG
|
A | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
PEG
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
PEG
|
E | 80.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
PEG
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
PEG
|
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
PEG
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
PEG
|
E | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
PEG
|
C | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PEG
|
A | 100.0 /93.1 |
5 /5 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PEG
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
FLC
|
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
P4G
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
P4G
|
D | 50.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EPE
|
E | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EPE
|
E | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
P6G
|
E | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
PGE
|
G | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PGE
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PGE
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
PGE
|
A | 57.1 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
1PE
|
G | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
1PE
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
TRS
|
A | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NO3
|
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |